DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,184,293 | +5.4% | 97,478 | +1.9% | 1.39% | +9.6% |
| Q2 2023 | $22,950,941 | +11.3% | 95,629 | +16.9% | 1.27% | +4.5% |
| Q1 2023 | $20,615,316 | -1.4% | 81,794 | +3.9% | 1.21% | -6.7% |
| Q4 2022 | $20,903,086 | +6.2% | 78,755 | +3.3% | 1.30% | -3.6% |
| Q3 2022 | $19,687,000 | +3.4% | 76,221 | +1.5% | 1.35% | +7.3% |
| Q2 2022 | $19,041,000 | -6.6% | 75,107 | +8.1% | 1.26% | +11.7% |
| Q1 2022 | $20,386,000 | -3.8% | 69,498 | +7.9% | 1.12% | +5.3% |
| Q4 2021 | $21,199,000 | +8.8% | 64,436 | +0.7% | 1.07% | -0.3% |
| Q3 2021 | $19,486,000 | +15.9% | 64,005 | +2.2% | 1.07% | +14.8% |
| Q2 2021 | $16,812,000 | +22.6% | 62,650 | +2.8% | 0.93% | +13.4% |
| Q1 2021 | $13,712,000 | +3.6% | 60,922 | +2.2% | 0.82% | -1.7% |
| Q4 2020 | $13,238,000 | +2.3% | 59,595 | -0.8% | 0.84% | -12.4% |
| Q3 2020 | $12,937,000 | +22.4% | 60,080 | +0.5% | 0.95% | +13.7% |
| Q2 2020 | $10,568,000 | +31.4% | 59,761 | +2.8% | 0.84% | +8.1% |
| Q1 2020 | $8,044,000 | +0.7% | 58,114 | +11.7% | 0.78% | +35.2% |
| Q4 2019 | $7,987,000 | +31.9% | 52,041 | +24.2% | 0.57% | +20.8% |
| Q3 2019 | $6,054,000 | +6.1% | 41,914 | +5.0% | 0.48% | +6.7% |
| Q2 2019 | $5,705,000 | +21.6% | 39,920 | +12.4% | 0.44% | +17.1% |
| Q1 2019 | $4,691,000 | +151.1% | 35,531 | +96.2% | 0.38% | +114.7% |
| Q4 2018 | $1,868,000 | -0.4% | 18,110 | +4.9% | 0.18% | +17.2% |
| Q3 2018 | $1,875,000 | +10.0% | 17,259 | -0.1% | 0.15% | +3.4% |
| Q2 2018 | $1,705,000 | +0.7% | 17,275 | -0.1% | 0.15% | -3.9% |
| Q1 2018 | $1,693,000 | +6.7% | 17,294 | +1.2% | 0.15% | +7.0% |
| Q4 2017 | $1,587,000 | +7.8% | 17,097 | -0.4% | 0.14% | -2.7% |
| Q3 2017 | $1,472,000 | +1.7% | 17,163 | +0.0% | 0.15% | -0.7% |
| Q2 2017 | $1,448,000 | -1.2% | 17,162 | +0.2% | 0.15% | -5.2% |
| Q1 2017 | $1,465,000 | +9.0% | 17,127 | -0.8% | 0.16% | +4.7% |
| Q4 2016 | $1,344,000 | -1.5% | 17,260 | -0.9% | 0.15% | -3.9% |
| Q3 2016 | $1,365,000 | -23.3% | 17,419 | -1.1% | 0.15% | -25.6% |
| Q2 2016 | $1,780,000 | -5.8% | 17,619 | -11.6% | 0.21% | -6.3% |
| Q1 2016 | $1,890,000 | +4.4% | 19,929 | +2.2% | 0.22% | +1.4% |
| Q4 2015 | $1,811,000 | -0.4% | 19,494 | -8.7% | 0.22% | -4.0% |
| Q3 2015 | $1,819,000 | -59.8% | 21,344 | -59.6% | 0.23% | -55.8% |
| Q2 2015 | $4,523,000 | -14.3% | 52,847 | -15.0% | 0.51% | -14.0% |
| Q1 2015 | $5,280,000 | -20.8% | 62,191 | -20.0% | 0.60% | -21.5% |
| Q4 2014 | $6,666,000 | +13.3% | 77,767 | +0.5% | 0.76% | +8.7% |
| Q3 2014 | $5,882,000 | -3.0% | 77,406 | +0.6% | 0.70% | -0.7% |
| Q2 2014 | $6,061,000 | +5.3% | 76,981 | +0.3% | 0.71% | +2.3% |
| Q1 2014 | $5,758,000 | -6.0% | 76,784 | -3.3% | 0.69% | -7.0% |
| Q4 2013 | $6,127,000 | +8.8% | 79,374 | -2.3% | 0.74% | +0.8% |
| Q3 2013 | $5,631,000 | +18.5% | 81,223 | +8.2% | 0.74% | +10.8% |
| Q2 2013 | $4,752,000 | – | 75,078 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |